Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH banner about website updates and the transition from “Artificial Intelligence” to “Super Intelligence” was removed.SummaryDifference1%

- Check12 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.3%

- Check19 days agoChange DetectedA site-wide notice announces updates to NIH websites and says “Super Intelligence” is replacing “Artificial Intelligence” in some federal-agency content.SummaryDifference1%

- Check26 days agoChange DetectedThe footer displays a newer ClinicalTrials.gov site revision number.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual study details with an error screen and a Home link. This prevents viewing essential trial information and attached documents.SummaryDifference20%

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.